Related Experiment Videos
Polymorphism of debrisoquine hydroxylation among Finns and Lapps
P Arvela1, M Kirjarinta, M Kirjarinta
1Department of Pharmacology, University of Oulu, Finland.
British Journal of Clinical Pharmacology
|November 1, 1988
Abstract:
Debrisoquine hydroxylation polymorphism was studied in 155 Finns and 70 Lapps. The frequency of the poor metabolizer phenotype was 3.2% among Finns (95% confidence interval 0.4-6.0%) and 8.6% among Lapps (95% confidence interval 2.0-15.1%).